Detalhe da pesquisa
1.
Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2.
Acta Pharmacol Sin
; 41(11): 1446-1456, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32398684
2.
OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition.
Acta Pharmacol Sin
; 37(10): 1359-1369, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27264313
3.
Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent models.
Biochem Biophys Res Commun
; 466(4): 740-7, 2015 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26417688
4.
Emodin, an 11ß-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice.
Acta Pharmacol Sin
; 33(9): 1195-203, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22922341
5.
Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect.
Sci Rep
; 6: 28676, 2016 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339735
6.
Bioactive compounds from Peperomia pellucida.
J Nat Prod
; 69(2): 247-50, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16499324